Odycell Nanotherapies Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Early Stage VC
- (Upcoming)
- Investors
-
1
Odycell Nanotherapies General Information
Description
Developer of a nanoparticle platform designed to support targeted oncology therapies. The company's platform reprograms tumor-associated macrophages and promotes immune-cell infiltration within immune-excluded tumors, converting them into immune-active tumor environments while supporting systemic anti-tumor immune responses and the development of durable immunological memory, enabling healthcare providers and oncology researchers to develop scalable nanotherapy approaches for cancer treatment.
Contact Information
Website
www.odycell.bioCorporate Office
- Argentina
Corporate Office
- Argentina
Odycell Nanotherapies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | Upcoming | Generating Revenue | ||||
| 1. Early Stage VC | 12-Aug-2026 | Completed | Generating Revenue |
Odycell Nanotherapies Signals
Odycell Nanotherapies Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CITES | Venture Capital | Minority |
Odycell Nanotherapies FAQs
-
When was Odycell Nanotherapies founded?
Odycell Nanotherapies was founded in 2025.
-
Where is Odycell Nanotherapies headquartered?
Odycell Nanotherapies is headquartered in Argentina.
-
What is the size of Odycell Nanotherapies?
Odycell Nanotherapies has 2 total employees.
-
What industry is Odycell Nanotherapies in?
Odycell Nanotherapies’s primary industry is Biotechnology.
-
Is Odycell Nanotherapies a private or public company?
Odycell Nanotherapies is a Private company.
-
What is Odycell Nanotherapies’s current revenue?
The current revenue for Odycell Nanotherapies is .
-
How much funding has Odycell Nanotherapies raised over time?
Odycell Nanotherapies has raised $100K.
-
Who are Odycell Nanotherapies’s investors?
CITES has invested in Odycell Nanotherapies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process